---
title: "非营利组织正面临捐赠者流失，并寻求新的筹款模式以实现变革；DickersonBakker 的总裁在北卡罗来纳州罗利倡导进行重组"
description: "北卡罗来纳州罗利的 DickersonBakker 新任总裁最近强调了非营利组织需要调整其筹款策略，以应对各种障碍。美国各地的非营利组织正经历捐赠者显著减少的情况，迫切需要采取措施来解决这一问题。截至 2026 年 1 月 27 日，该行业正面临慈善捐赠潜在危机，亟需创新的方法来确保重要的财务支持"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/273869641.md"
published_at: "2026-01-27T16:06:04.000Z"
---

# 非营利组织正面临捐赠者流失，并寻求新的筹款模式以实现变革；DickersonBakker 的总裁在北卡罗来纳州罗利倡导进行重组

> 北卡罗来纳州罗利的 DickersonBakker 新任总裁最近强调了非营利组织需要调整其筹款策略，以应对各种障碍。美国各地的非营利组织正经历捐赠者显著减少的情况，迫切需要采取措施来解决这一问题。截至 2026 年 1 月 27 日，该行业正面临慈善捐赠潜在危机，亟需创新的方法来确保重要的财务支持

位于北卡罗来纳州罗利的 DickersonBakker 新任总裁最近强调了非营利组织需要调整其筹款策略，以应对各种障碍。美国各地的非营利组织正经历捐赠者数量的显著下降，迫切需要采取措施来解决这一问题。截至 2026 年 1 月 27 日，该行业正面临慈善捐赠潜在危机，亟需创新的方法来确保重要的财务支持。

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences | Hims & Hers Health Inc. (NYSE:HIMS) shares fell 6.90% to $14.44 in premarket trading after reporting mixed Q4 earnings.  | [Link](https://longbridge.com/zh-CN/news/276744332.md) |
| First Solar In The Spotlight Ahead Of Q4 Earnings | First Solar, Inc. (NASDAQ:FSLR) is trending ahead of its Q4 earnings report, expected to show EPS of $5.15 and revenue o | [Link](https://longbridge.com/zh-CN/news/276757729.md) |
| QUOTES-Analysts' comments after Anthropic unveils new plug-ins | On February 24, Anthropic introduced 10 new plug-ins aimed at enhancing business operations in investment banking, wealt | [Link](https://longbridge.com/zh-CN/news/276760305.md) |
| Apple Navigated Around Tariffs, Now It Faces 'Confusion Zone' From Supreme Court Ruling | Apple Inc faces renewed uncertainty regarding tariffs following a Supreme Court ruling against Trump's tariffs. The ruli | [Link](https://longbridge.com/zh-CN/news/276638942.md) |
| BUZZ-Larimar jumps on FDA's 'breakthrough' tag for neurological disorder therapy | Shares of therapy developer Larimar Therapeuticsjump 32% to $3.71 premarketCo says the U.S. FDA granted a breakthrough d | [Link](https://longbridge.com/zh-CN/news/276742755.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。